Manufacturing news briefs – stories you might have missed
Anti depression drug developer Bionomics completes equity raising Bionomics has successfully completed an over-subscribed equity raising from current shareholders, raising $2.2 million before costs. The raising will accelerate the commercialisation of the company’s drug candidate, BNC210 for the treatment of post traumatic stress disorder. The company is also developing drugs for the treatment of pain,…